PML Cases now 372

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

PML Cases now 372

Postby HarryZ » Sat Jun 22, 2013 6:58 pm

The number of PML cases has risen another 13 during the past month, bringing the new total to 372. It isn't slowing down!

http://chefarztfrau.de/?page_id=716

Harry
User avatar
HarryZ
Family Elder
 
Posts: 2557
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada

Advertisement

Re: PML Cases now 372

Postby lena-g » Fri Aug 23, 2013 2:15 pm

Alexander Otto
23. August 2013 um 08:33
As of Aug 6, 2013, there have been 395 confirmed cases of PML worldwide (131) in the US).

92 of 395 (23%) of the patients with PML have died; the patients who
are alive have varying levels of disability, ranging from severe to
moderate to mild. PML usually leads to death or severe disability.

As of June 30, 2013, approximately 118,100 patients received natalizumab in post-marketing setting worldwide.
User avatar
lena-g
Getting to Know You...
 
Posts: 14
Joined: Mon May 17, 2010 2:00 pm

Re: PML Cases now 372

Postby lena-g » Fri Aug 23, 2013 2:30 pm

July: +13
August: +18

It's terrible! :YMSICK:
User avatar
lena-g
Getting to Know You...
 
Posts: 14
Joined: Mon May 17, 2010 2:00 pm

Re: PML Cases now 372

Postby HarryZ » Fri Aug 23, 2013 4:50 pm

lena-g wrote:July: +13
August: +18

It's terrible! :YMSICK:


Beyond terrible!! Despite all the JCV testing and other precautions, the number of PML cases continues to rise with alarming numbers.

Harry
User avatar
HarryZ
Family Elder
 
Posts: 2557
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada

Re: PML Cases now 372

Postby HarryZ » Wed Sep 25, 2013 6:57 am

Guess we are up to 401 PML cases now!
User avatar
HarryZ
Family Elder
 
Posts: 2557
Joined: Tue May 25, 2004 2:00 pm
Location: London, ON, Canada


Return to Tysabri (Antegren or Natalizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service